Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 13, 2009Journal of Clinical InvestigationOpen Access

Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth

View Full Paper
Ask AI
Bookmark
Share

Authors

NSNeelesh SomanPfizer (United States)SBSteven L. BaldwinWashington University in St. LouisGHGrace HuColumbia University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Soman et al. (2009) studied this question.

synapsesocial.com/papers/69dbd8187d378569a98363behttps://doi.org/10.1172/jci38842
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fast and slow orientational fluctuations in membranes1985 · 23 citations
  2. 2Bee keepers' IgG and IgE antibody responses to bee venom studied by means of crossed radioimmunoelectrophoresis1984 · 26 citations
  3. 3Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging2008 · 68 citations